Literature DB >> 16105991

Healing Achilles--sirolimus versus paclitaxel.

David J Moliterno.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105991     DOI: 10.1056/NEJMe058140

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

2.  mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

Authors:  Andrew S Weyrich; Melvin M Denis; Hansjorg Schwertz; Neal D Tolley; Jason Foulks; Eliott Spencer; Larry W Kraiss; Kurt H Albertine; Thomas M McIntyre; Guy A Zimmerman
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

3.  Role of drug eluting stents in diabetic patients.

Authors:  F Boccara; E Teiger; A Cohen
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

4.  Percutaneous coronary intervention, a historical perspective looking to the future.

Authors:  Johan Bennett; Christophe Dubois
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

5.  Drug-eluting stents for all patients.

Authors:  A T L Ong; W J van der Giessen
Journal:  Neth Heart J       Date:  2006-05       Impact factor: 2.380

6.  [Association of CMTM5 gene expression with the risk of in-stent restenosis in patients with coronary artery disease after drug-eluting stent implantation and the effects and mechanisms of CMTM5 on human vascular endothelial cells].

Authors:  T F Liu; T Lin; L H Ren; G P Li; J J Peng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-10-18

Review 7.  Biodegradable Metals for Cardiovascular Stents: from Clinical Concerns to Recent Zn-Alloys.

Authors:  Patrick K Bowen; Emily R Shearier; Shan Zhao; Roger J Guillory; Feng Zhao; Jeremy Goldman; Jaroslaw W Drelich
Journal:  Adv Healthc Mater       Date:  2016-04-20       Impact factor: 9.933

Review 8.  Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment.

Authors:  Robert A Byrne; Nikolaus Sarafoff; Adnan Kastrati; Albert Schömig
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease.

Authors:  Johan Bennett; Christophe Dubois
Journal:  Biologics       Date:  2013-06-19

Review 10.  Clinical utility of platinum chromium bare-metal stents in coronary heart disease.

Authors:  Claudia Jorge; Christophe Dubois
Journal:  Med Devices (Auckl)       Date:  2015-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.